Director of the National Respiratory Disease Clinical Research Center, leader of the national key discipline of respiratory diseases, leader of the innovation team of respiratory and pulmonary circulation diseases of the Ministry of Science and Technology, chairman of the Respiratory Branch of the Chinese Medical Association, and honorary academician of the Imperial College London Medical Department in London, England.

He has been engaged in medical teaching and research in the fields of pulmonary embolism and pulmonary hypertension, respiratory failure and respiratory support technology, new respiratory infectious diseases, chronic obstructive pulmonary disease and tobacco science for a long time. Many important innovations such as half-dose thrombolytic therapy and sequential mechanical ventilation therapy for pulmonary embolism have been made, and they have entered the international diagnosis and treatment guidelines. Vigorously promote the national tobacco control work. Undertake a number of national key scientific research projects and international scientific research projects.

Member of the editorial steering committee of British Medical Journal (BMJ), editor-in-chief of Chest, editor-in-chief of Clinical Respiratory Journal and editor-in-chief of China Medical Journal. He has published more than 65,438+000 articles in international authoritative medical journals such as New England Journal of Medicine and The Lancet. Won the first prize of national scientific and technological progress 1 item and the second prize of national scientific and technological progress 3 items. Won the World Health Organization Outstanding Contribution Award for Tobacco Control and the He Liang Heli Fund Science and Technology Progress Award.